Category: Uncategorized
-

Palo Alto Networks (PANW) Stock Makes Too Much Sense to Ignore
While the business ecosystem may be focused almost entirely on gen AI, the cybersecurity risks that machine learning imposes make considering PANW stock a no-brainer.
-

Here’s How to Max Out Broadcom (AVGO) Stock Options’ Profit Potential
While analyzing the future potential outcomes of AVGO stock is important, it’s just one component of the risk topography game.
-

Stock Splits in 2026: 3 Names That Could Soar in the New Year
Stock splits are one of the most important signals to watch as investors position for 2026. While stock splits don’t change a company’s underlying valuation, they often create meaningful ripple effects: greater liquidity, improved affordability for retail investors, and renewed institutional interest from funds that are more price-sensitive. After all, if an attractive $500 stock…
-

Why LVS Stock May Be Near a Tactical Inflection Point
Quant analysis suggests LVS stock may be nearing a tactical pullback, setting up a bear put spread opportunity based on risk geometry and probability clustering.
-

3 Mining Stocks with the Potential for Explosive Upside
Metals and mining stocks are notoriously cyclical in nature. However, 2025 has presented investors with a perfect storm of sorts for those pursuing the metals trade. The debasement trade in gold is well-documented and will continue into 2026 and beyond. That trade is also beginning to show up in the price of silver, which may overtake…
-

3 Dividend Stocks to Own as More Americans Rent Instead of Buy
Many income investors will say there’s never a bad time to look for dividend stocks to own. However, there’s a clear reason why high-yield dividend stocks may become fashionable for growth and income investors. The reason is that more Americans are renting again. In fact, as noted by Fortune.com, “For the first time since 2016,…
-

4 Gene Editing Stocks to Transform Your Portfolio
Gene editing stocks have gone from speculative and theoretical to commercially viable. In December 2023, the United States Food & Drug Administration (FDA) approved the first CRISPR therapies. That’s changed the conversation from “if” to “how fast.” How fast may take longer than some investors would like. However, it means there’s still an opportunity to invest in gene editing stocks while a long runway…
-

CAT Stock Rises After Earnings: Momentum Builds
Caterpillar Inc. (NYSE: CAT) stock is considered a bellwether because demand for its products is a signal for the broader economy. So, it’s important to understand why CAT stock is up more than 12% after earnings, and why it may just be getting started. The headline numbers for the company’s report were strong. Revenue of $17.64 billion beat expectations for $16.77 billion by a comfortable 5.15%. Earnings per share…
-

Nucor Earnings Beat Lifts Shares Despite Price Pressure
Nucor Corp. (NYSE: NUE) delivered strong third-quarter earnings on October 28. NUE stock was up nearly 5.5% in the final hour of trading after the company posted a beat on the top and bottom lines. Even with the company guiding for lower revenue and earnings in the current quarter, investors liked what they heard. Revenue of $8.52 billion beat estimates for…
-

Two Best-in-Class Gold Stocks to Buy on the Dip
Has the gold trade lost its luster? After surging to nearly $4,400 an ounce, the spot price of gold has fallen back to around $4,000 an ounce. But is gold simply taking a break or is this the beginning of a longer turn reversal in the yellow metal’s price? And how does that affect the case for gold stocks?…